These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8982708

  • 1. [3H]RX821002 (2-methoxyidazoxan) binds to alpha 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney.
    Callado LF, Gabilondo AM, Meana JJ.
    Eur J Pharmacol; 1996 Dec 05; 316(2-3):359-68. PubMed ID: 8982708
    [Abstract] [Full Text] [Related]

  • 2. Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
    Callado LF, Meana JJ.
    Eur J Pharmacol; 1997 Jul 30; 332(1):109-12. PubMed ID: 9298931
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
    Callado LF, Gabilondo AM, Meana JJ.
    Life Sci; 1999 Jul 30; 64(25):2327-39. PubMed ID: 10374896
    [Abstract] [Full Text] [Related]

  • 4. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR, King PR, Louis WJ, Gundlach AL.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan 30; 355(1):131-8. PubMed ID: 9007853
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
    Wallace DR, Muskardin DT, Zahniser NR.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):67-76. PubMed ID: 7925601
    [Abstract] [Full Text] [Related]

  • 6. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1993 Mar 02; 264(3):1187-97. PubMed ID: 8095548
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.
    Uhlén S, Muceniece R, Rangel N, Tiger G, Wikberg JE.
    Pharmacol Toxicol; 1995 Jun 02; 76(6):353-64. PubMed ID: 7479575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
    Mallard NJ, Hudson AL, Nutt DJ.
    Br J Pharmacol; 1992 Aug 02; 106(4):1019-27. PubMed ID: 1356565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK, Blaylock NA, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Feb 02; 114(3):678-88. PubMed ID: 7735695
    [Abstract] [Full Text] [Related]

  • 12. Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding.
    Uhlén S, Wikberg JE.
    Pharmacol Toxicol; 1991 Nov 02; 69(5):341-50. PubMed ID: 1687079
    [Abstract] [Full Text] [Related]

  • 13. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A, Widdowson PS, Cordi A.
    Br J Pharmacol; 1993 Jul 02; 109(3):625-31. PubMed ID: 8102932
    [Abstract] [Full Text] [Related]

  • 14. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
    Colucci R, Blandizzi C, Carignani D, Placanica G, Lazzeri G, Del Tacca M.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun 02; 357(6):682-91. PubMed ID: 9686946
    [Abstract] [Full Text] [Related]

  • 15. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
    Uhlén S, Wikberg JE.
    Br J Pharmacol; 1991 Nov 02; 104(3):657-64. PubMed ID: 1665747
    [Abstract] [Full Text] [Related]

  • 16. Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium.
    Musgrave IF, Seifert R.
    Biochem Pharmacol; 1995 Jan 18; 49(2):187-96. PubMed ID: 7530955
    [Abstract] [Full Text] [Related]

  • 17. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM, MacKinnon AC, McGrath JC, Spedding M, Kilpatrick AT.
    Br J Pharmacol; 1990 Apr 18; 99(4):803-9. PubMed ID: 1972896
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ, Likungu J, Jakschik J, Göthert M.
    Br J Pharmacol; 1997 Sep 18; 122(1):43-50. PubMed ID: 9298527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
    Chan SL, Brown CA, Scarpello KE, Morgan NG.
    Br J Pharmacol; 1994 Aug 18; 112(4):1065-70. PubMed ID: 7952865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.